Cargando…

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis

In almost all cases, hepatocellular carcinoma (HCC) develops as the endpoint of a sequence that starts with chronic liver injury, progresses to liver cirrhosis, and finally, over years and decades, results in liver cancer. Recently, the role of non-coding RNA such as microRNA (miRNA) has been demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Raphael, Özdirik, Burcin, Lambrecht, Joeri, Demir, Münevver, Eschrich, Johannes, Geisler, Lukas, Hellberg, Teresa, Loosen, Sven H., Luedde, Tom, Tacke, Frank, Hammerich, Linda, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867354/
https://www.ncbi.nlm.nih.gov/pubmed/33540837
http://dx.doi.org/10.3390/ijms22031492
_version_ 1783648283756855296
author Mohr, Raphael
Özdirik, Burcin
Lambrecht, Joeri
Demir, Münevver
Eschrich, Johannes
Geisler, Lukas
Hellberg, Teresa
Loosen, Sven H.
Luedde, Tom
Tacke, Frank
Hammerich, Linda
Roderburg, Christoph
author_facet Mohr, Raphael
Özdirik, Burcin
Lambrecht, Joeri
Demir, Münevver
Eschrich, Johannes
Geisler, Lukas
Hellberg, Teresa
Loosen, Sven H.
Luedde, Tom
Tacke, Frank
Hammerich, Linda
Roderburg, Christoph
author_sort Mohr, Raphael
collection PubMed
description In almost all cases, hepatocellular carcinoma (HCC) develops as the endpoint of a sequence that starts with chronic liver injury, progresses to liver cirrhosis, and finally, over years and decades, results in liver cancer. Recently, the role of non-coding RNA such as microRNA (miRNA) has been demonstrated in the context of chronic liver diseases and HCC. Moreover, data from a phase II trial suggested a potential role of microRNAs as therapeutics in hepatitis-C-virus infection, representing a significant risk factor for development of liver cirrhosis and HCC. Despite progress in the clinical management of chronic liver diseases, pharmacological treatment options for patients with liver cirrhosis and/or advanced HCC are still limited. With their potential to regulate whole networks of genes, miRNA might be used as novel therapeutics in these patients but could also serve as biomarkers for improved patient stratification. In this review, we discuss available data on the role of miRNA in the transition from liver cirrhosis to HCC. We highlight opportunities for clinical translation and discuss open issues applicable to future developments.
format Online
Article
Text
id pubmed-7867354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78673542021-02-07 From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis Mohr, Raphael Özdirik, Burcin Lambrecht, Joeri Demir, Münevver Eschrich, Johannes Geisler, Lukas Hellberg, Teresa Loosen, Sven H. Luedde, Tom Tacke, Frank Hammerich, Linda Roderburg, Christoph Int J Mol Sci Review In almost all cases, hepatocellular carcinoma (HCC) develops as the endpoint of a sequence that starts with chronic liver injury, progresses to liver cirrhosis, and finally, over years and decades, results in liver cancer. Recently, the role of non-coding RNA such as microRNA (miRNA) has been demonstrated in the context of chronic liver diseases and HCC. Moreover, data from a phase II trial suggested a potential role of microRNAs as therapeutics in hepatitis-C-virus infection, representing a significant risk factor for development of liver cirrhosis and HCC. Despite progress in the clinical management of chronic liver diseases, pharmacological treatment options for patients with liver cirrhosis and/or advanced HCC are still limited. With their potential to regulate whole networks of genes, miRNA might be used as novel therapeutics in these patients but could also serve as biomarkers for improved patient stratification. In this review, we discuss available data on the role of miRNA in the transition from liver cirrhosis to HCC. We highlight opportunities for clinical translation and discuss open issues applicable to future developments. MDPI 2021-02-02 /pmc/articles/PMC7867354/ /pubmed/33540837 http://dx.doi.org/10.3390/ijms22031492 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mohr, Raphael
Özdirik, Burcin
Lambrecht, Joeri
Demir, Münevver
Eschrich, Johannes
Geisler, Lukas
Hellberg, Teresa
Loosen, Sven H.
Luedde, Tom
Tacke, Frank
Hammerich, Linda
Roderburg, Christoph
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title_full From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title_fullStr From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title_full_unstemmed From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title_short From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
title_sort from liver cirrhosis to cancer: the role of micro-rnas in hepatocarcinogenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867354/
https://www.ncbi.nlm.nih.gov/pubmed/33540837
http://dx.doi.org/10.3390/ijms22031492
work_keys_str_mv AT mohrraphael fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT ozdirikburcin fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT lambrechtjoeri fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT demirmunevver fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT eschrichjohannes fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT geislerlukas fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT hellbergteresa fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT loosensvenh fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT lueddetom fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT tackefrank fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT hammerichlinda fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis
AT roderburgchristoph fromlivercirrhosistocancertheroleofmicrornasinhepatocarcinogenesis